Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Pediatric Sedation in Congenital Heart Disease
ChiCTR-OPC-16009842Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in Cardiovascular Malformation (CVM) (3 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: MOAA/S score and Aldrete score. Started Nov 2016; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR-OPC-16009842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16009842.